There is lack of data about the agreement of minimally invasive cardiac output monitors, which make it impossible to determine if they are interchangeable or differ objectively in tracking physiological trends. We studied three commonly used devices: the oesophageal Doppler and two arterial pressure-based devices, the Vigileo FloTrac™ and LiDCOrapid™. The aim of this study was to compare the agreement of these three monitors in adult patients undergoing elective non-cardiac surgery. Measurements were taken at baseline and after predefined clinical interventions of fluid, metaraminol or ephedrine bolus. From 24 patients, 131 events, averaging 5.2 events per patient, were analysed. The cardiac index of LiDCOrapid versus FloTrac had a mean bias of -6.0% (limits of agreement from -51% to 39%) and concordance of over 80% to the three clinical interventions. The cardiac index of Doppler versus LiDCOrapid and Doppler versus FloTrac, had an increasing negative bias at higher mean cardiac outputs and there was significantly poorer concordance to all interventions. Of the preload-responsive parameters, Doppler stroke volume index, Doppler systolic flow time and FloTrac stroke volume variation were fair at predicting fluid responsiveness while other parameters were poor. While there is reasonable agreement between the two arterial pressure-derived cardiac output devices (LiDCOrapid and Vigileo FloTrac), these two devices differ significantly to the oesophageal Doppler technology in response to common clinical intraoperative interventions, representing a limitation to how interchangeable these technologies are in measuring cardiac output.
Minimally invasive cardiac output (CO) monitors offer the ability to estimate a patient's stroke volume or cardiac output. They also offer dynamic parameters that can predict fluid responsiveness, such as stroke volume variation, pulse pressure variation and systolic flow time. They can be used as part of goal-directed therapy (GDT) in perioperative and critical care settings and there are outcomes studies that suggest a benefit over standard practice 1,2. . The assessment of cardiac output monitors has largely relied upon bias and precision and the derivation of percentage error using Bland-Altman analysis. However, this technique has limits; Peyton and Chong found in a meta-analysis of four different technologies, pulse contour techniques, oesophageal Doppler, partial carbon dioxide rebreathing and transthoracic electrical bioimpedance, that they all have very similar percentage errors (41.3-44.5%) 3 . However, they observed that reliable real-time tracking of changes in cardiac output is arguably more important. The performance of minimally invasive cardiac output devices needs testing in the clinical environment and in response to different clinical interventions such as vasopressor or fluid administration. A lack of agreement in these scenarios would make the assumption that they are interchangeable incorrect, and could lead to misleading and potentially harmful diagnostic and management decisions 4 . In a study in cardiac surgery patients, the responses of the oesophageal Doppler (OD), LiDCOrapid™ (LI) and Vigileo FloTrac™ (FT) in response to fluid and metaraminol interventions were quite different with limited concordance between the devices 5 . Further studies looking at non-commercial arterial pressure algorithms have shown that concordance to fluid and vasopressor with Doppler-derived cardiac output is limited, in all but one study by Liljestrand-Zander 6 . Similarly, tracking changes to dopamine infusion were limited with arterial pressure-derived algorithms in a study of 20 patients using two techniques of Doppler-derived cardiac output 7 .
The aim of this study was to compare agreement of cardiac output measurements during common clinical interventions (fluid administration and metaraminol and ephedrine boluses); although without a secondary reference method, we could not directly test accuracy. Our hypothesis was that devices measuring the same physiological parameter/s should show good concordance in response to common clinical haemodynamic interventions. A secondary aim was to analyse the ability of preload-sensitive parameters to predict fluid responsiveness.
Materials and Methods
Approval from our local ethics committee (St Vincent's Hospital, Melbourne, Victoria, ref HREC-D 050/08, 30/7/2008) with written patient consent was obtained prospectively, and the study was registered with the Australian and New Zealand Clinical Trials Registry (ACTRN12609000407291). We evaluated 24 adult non-cardiac patients over a ten month period with consecutive enrolment, but limited by consent and investigator availability. Inclusion criteria were major surgery with significant blood loss, age >18 years and availability of an investigator. Patients with atrial fibrillation, a preoperative diagnosis of aortic regurgitation or a contraindication to an oesophageal probe were excluded. Every patient was monitored with all three test devices.
A radial arterial line (20G Angiocath™, Dickinson Infusion Therapy Systems, Sandy, UT, USA) was inserted in the sedated patient prior to induction of general anaesthesia. An anaesthetic was given based on midazolam, fentanyl, and propofol induction with sevoflurane maintenance. The choice of muscle relaxant was left to the anaesthetist. The arterial line was connected to the FT transducer, which has two output cables, providing a signal to both the FT device and the anaesthetic monitor, a Datex-Ohmeda S/5. The LI device obtains the arterial waveform for analysis via a cable from the anaesthetic monitor. The OD probe was inserted after induction of general anaesthesia by one of three investigators, all of whom were experienced in its use in over 12 patients. The patient, anaesthetist, and surgical team were blinded to the test device readings.
Study protocol
The internal clocks of all devices were synchronised and event readings were undertaken at discrete time points including baseline, pre-event and post-event readings. The investigator would optimise the Doppler signal. Concurrent measurements of all three devices were then performed with events captured during the same time epoch. The LI monitor was used to create a time marker that would serve to pinpoint the period when the trends were analysed offline. OD readings comprised the cardiac index (CI OD ), stroke volume index (SVI OD ), stroke volume variation (SVV OD ) and corrected flow time (FlowTime OD ); the parameters are updated every 30 seconds from an average of five cardiac cycles. Flow time is the total time of forward flow in the descending aorta and represents the systolic interval and varies with the heart rate. It is corrected to a heart rate of 60 /minute using a derivation of Bazett's equation, which is similarly used to correct the QT interval in an electrocardiograph 8 . FT readings, updated every 20 seconds, comprised the cardiac index (CI FT ), stroke volume index (SVI FT ) and stroke volume variation (SVV FT ). FT software version 1.14 was current at the start of the study (used for the first 18 patients), but was updated to version 3.0 (six patients), designed to improve accuracy. LI readings comprised cardiac index (CI LI ), stroke volume index (SVI LI ), stroke volume variation (SVV LI ) and pulse pressure variation (PPV LI ), which are displayed on a beat-to-beat basis, but were analysed as a 20 second average in order to be consistent with FT.
Readings from the OD and the FT were entered into a spreadsheet as they were taken. Basic physiological variables (blood pressure, heart rate) and readings from LI were analysed offline using the LiDCO view™ program (LiDCO Pty Ltd, Cambridge, Cambridgeshire, UK) which automatically archives all LI data.
The events were initiated by the treating anaesthetist according to clinical need. The investigator undertook readings of an event when they were notified that i) fluid was to be administered as a bolus in response to clinical hypotension or hypovolaemia, ii) metaraminol was to be given in response to hypotension, or iii) ephedrine was to be given for hypotension. Prior to the event, a baseline reading was taken. The post-event readings were taken when any haemodynamic change had plateaued for a minimum of 60 seconds. This allowed all three devices adequate time to update their readings. A response was measured only when there was a single intervention occurring. Events also had to be free of confounders such as changes in patient position or change in depth of anaesthesia. We estimated that an average of four events would occur per patient yielding 96 events for analysis.
Statistics

Bias and limits of agreement
All CI measurements were compared using Bland-Altman analysis to determine bias and limits of agreement (limits of agreement = mean ± 2 standard deviation [SD]) of each test device compared to each other with correction for multiple observations per individual 9 .
Trend analysis
For each fluid, metaraminol and ephedrine event, agreement in direction of CI changes between monitors was assessed. Concordance plots of change in CI of pairs of test devices (OD versus FT, OD versus LI, FT versus LI) were plotted. We defined concordance as the percentage of data points where both test devices record the same directional change with a 10% exclusion zone. An exclusion zone is recommended to remove the 'noise' associated with small changes in cardiac output 10 . The statistical significance of the different percentages of concordance between pairs of devices and different types of events was assessed with a logistic regression model, with device pair and event as predictors and concordance as a dichotomous outcome. The Stata "binreg" command with the relative risk option was used for these calculations. Significance was assumed at a P value <0.05.
Predictors of fluid responsiveness
We used the devices' own derived estimation of the SV to assess fluid responsiveness. This provided internal validity and avoided the difficulty of determining which was the true reference method.
Receiver operating characteristic (ROC) curve analysis was used to determine the sensitivity and specificity of using different cut-off values of various parameters to predict fluid responsiveness, which was defined as a 10% or greater increase in cardiac index, a threshold that is consistently used in GDT algorithms 11 . The optimum threshold value was chosen as that which gave the maximum value for the sum of the sensitivity and specificity (Youden index), i.e. the point on the ROC furthest from the line of equality (y = x). A 'grey zone' for the threshold was determined. This was defined as the range of thresholds with a sensitivity or specificity lower than 90% as described by Cannesson et al 12 .
Sample size
To detect a difference in concordance rate of 20% between pairs of monitors, assuming an overall concordance rate of 75% (alpha of 0.05, power of 0.8) would require a sample size of 73 events. We thus studied 24 patients as we estimated an average of four events per patient and that approximately 25% of the events would have measurements excluded from the concordance analysis as they would be within the 10% exclusion zone.
All analyses were performed using Stata 12™ (StataCorp LP, College Station, TX, USA).
Results
We studied 24 patients (Table 1) , in whom 131 events were captured with a median of five events per patient (interquartile range [IQR] 3-6.5, range 1-16 events). Of the interventions, the mean fluid bolus volume was 258 ml (SD 37 ml), median metaraminol dose 0.5 mg (range 0.25-1 mg) and median ephedrine dose 6 mg (range 3-6 mg).
Bias and limits of agreement
As the Bland-Altman plot of CI LI vs CI FT using the absolute dCI (d=change) showed heteroscedasticity (there was higher variability with increased mean CI) we plotted the difference between methods as a percentage of their average on the vertical axis 9 . Figure 1a shows a mean bias of -6.0%, with limits of agreement from -51% to 39%. The plots of CI FT vs CI OD (Figure 1b ) and CI LI vs CI OD (Figure 1c ) utilised traditional Bland-Altman analysis with absolute dCI on the Y axis as they did not demonstrate heteroscedasticity. However, both these plots showed an increasing negative bias as the CI increased. Hence we did not present the mean bias for CI LI -CI OD or CI FT -CI OD because it would be misleading given the increasing negative bias with higher CI. We thus used ordinary least squares regression to determine how the difference between measurements varied with their mean, and the standard error of the estimate to determine the limits of agreement 9 . In both cases the upper and lower limits of agreement are roughly 2 l/min/m 2 above and below the lines of best fit, throughout the range of cardiac indices.
Trend Analysis
The pairwise concordance plots of the responses of the three monitors to fluid, metaraminol and ephedrine events ( Fig. 2a, 2b, 2c respectively) show overall (all events combined) the concordance was lower for comparisons between pulse contour and oesophageal devices than for the two pulse contour devices (relative chance of concordance = 0.55 [95% confidence interval 0.47-0.66], P <0.001). This was mainly due to the low concordance between pulse contour and oesophageal Doppler devices for metaraminol events (relative chance of concordance = 0.35 [95% confidence interval 0.25-0.48], P <0.001). Table 2 summarises and compares the percentages of concordance.
Predictors of fluid responsiveness
ROC curves for fluid responsive parameters are presented for SVI and FlowTime OD (Fig. 3a) and . respiratory coupled parameters (Fig. 3b ). ROC curves (Table 3) with the sensitivity and specificity at the optimal thresholds suggest that in this setting some of the parameters (SVI OD , SVV OD, FlowTime OD and Figure 3a : Receiver Operating Characteristic curve for SVI LI, SVI FT, SVI OD and corrected FlowTime OD . Asterisked points represent optimum threshholds (Youden Indices) listed in Table 3 . SVI = stroke volume index, FT = FloTrac, OD = oesophageal Doppler, LI = LiDCOrapid. Table 3 . FT = FloTrac, OD = oesophageal Doppler, LI = LiDCOrapid, SVV = stroke volume variation, PPV = pulse pressure variation. SVV FT ) are fair at predicting fluid responsiveness, and the remainder are poor.
Discussion
This study was designed to assess the agreement between three cardiac output monitors during clinically relevant haemodynamic interventions.
Bland-Altman analysis
While there are multiple validation studies comparing minimally invasive cardiac output monitors to thermodilution, there are fewer studies comparing the monitors to each other. Bland-Altman plot analysis revealed small bias and reasonable precision between the two arterial CO monitors, FT and LI (bias -0.6%, limits of agreement -50.7 to 38.8%) using a wider acceptable criteria for percentage error, <45%, advocated by Peyton et al in a review of cardiac output monitoring 3 . However, there was variable bias when CO FT and CO LI were compared with CO OD with a tendency to overestimate CO OD at low cardiac outputs and a tendency to underestimate CO OD at high cardiac outputs. Nordstrom et al compared the oesophageal Doppler to the LiDCOrapid in 20 patients with 86 fluid challenges and reported a percentage error of 70%. However, their Bland-Altman graph was very similar to our findings which we believe renders a single figure of bias and percentage error unhelpful 13 .
Studies looking at specific clinical scenarios have also found that the biases cannot be assumed to be minimal or constant. When compared to thermodilution, the arterial pressure-based FloTrac showed greater bias in earlier versions (version 1.07 and 1.10), under-reading the CO compared to the reference method, in patients with liver failure (Child-Pugh grade B or C) in whom abnormal haemodynamics of increased CO and lower mean arterial pressure (MAP) and systemic vascular resistance (SVR) predominate 14, 15 . Subsequent versions of FloTrac (3.02) seemed to have reduced the bias in low SVR states 16 . However, in an analysis of agreement and concordance between FloTrac (version 3.02) compared to thermodilution in cardiac surgical patients, it was found that the bias was still greater in both low and high SVR states compared to normal. At low SVR, FT underestimated the reference CO with a bias of 1.85 l/minute and overestimated at high SVR with a bias of 1.34 l/minute 17 .
As the oesophageal Doppler is not a gold standard cardiac output monitor, we would not be able to conclude which devices represented the more accurate estimation of cardiac output. Indeed, Critchley et al when comparing the oesophageal Doppler and the USCOM (Ultrasonic Cardiac Output Monitor) suprasternal Doppler, found that the oesophageal Doppler under-read at low CO and over-read at higher CO 18 . It has been repeatedly pointed out that the OD assumptions of a fixed cardiac output ratio between the upper and lower body may not hold true 19, 20 . Nevertheless, in a small study of only eight patients utilising a highly invasive aortic flow probe, arterial pulse pressure (LiDCOplus TM ) was found to underestimate stroke volume at higher left ventricular stroke volume values 21 .
Concordance to changes in CO
There was a fair to high degree of concordance between the two arterial pressure CO devices (FT and LI), to all tested clinical events: fluid 83%, metaraminol 86%, and ephedrine 100%; close to the recommended threshold of 90% for reliability as reviewed by Critchley et al in a review of trend analysis of cardiac output monitoring 10 . In contrast, there was poor concordance between the arterial pressure CO devices and OD, especially for metaraminol events (only 30%).
There are now a number of studies showing limitations in concordance between arterial pressure CO devices and the OD. For fluid boluses, Nordstrom et al compared LiDCOrapid and OD in major colorectal surgery and found that the concordance rate was 80% 13 . They also showed that LiDCOrapid estimations of SV correlated with MAP (r 2 0.45, P=0.001) while OD and MAP did not, intimating that LiDCOrapid has limitations in uncoupling estimations of SV from pressure. In a study comparing OD and FT, Meng et al found in trend analysis that there was a significant correlation between change in MAP and change in FT-measured CO for preload increase, phenylephrine and ephedrine events (r 2 0.11, P=0.02), highlighting the coupling between arterialderived CO monitors and systematic arterial pressure 22 . The authors of this study also reported a similar finding of a marked discrepancy in concordance between FT and OD to vasopressor events, 23% concordance to phenylephrine and 69% to ephedrine.
The close concordance between the arterial pressure CO monitors, LI and FT, in our study is in contrast to comparisons with another arterial pressure CO device which utilises pulse contour analysis and transpulmonary thermodilution, PiCCO 2 TM . In 20 critically ill patients, FT compared to PiCCO 2 demonstrated limited and poor concordance to fluid events (73%) and noradrenaline changes (60% ) 23 . The PiCCO technology allows for calibration using thermodilution which may explain differences in its performance compared to uncalibrated arterial pressure cardiac output monitors, FT and LI.
However, PiCCO 2 compared to OD also had limited agreement in an observational substudy of GDT fluid in ovarian surgery patients (41 patients and 762 fluid events) with a concordance rate of 67.8% 24 . The administration of noradrenaline (0.1 µg/kg/minute, odds ratio [OR] 0.606, P=0.016) and a change in MAP (10%, OR 0.733, P=0.001) during a fluid bolus was also associated with worse trend agreement between the two monitors.
In a review of trend analysis of cardiac output devices, Critchley et al identified few publications looking at trend analysis for events. Of the available evidence, they concluded that pulse contour devices are less reliable compared to Doppler-derived CO because they fail to compensate for circulatory changes in peripheral resistance 10 . The strength of this study is that by incorporating two arterial pressure CO devices we can observe that these limitations in concordance are possibly technology-class specific which would be in keeping with observations by Zhang et al who found the concordance between oesophageal and suprasternal Doppler (94%) was better than with any of the five non-commercial arterial pressure waveform algorithms incorporated in the CardioQ-Combi™ (Deltex Medical, Chichester, UK) monitor (64-71%) to cardiac output changes due to dopamine infusions 7 . Using the same research monitor, CardioQ-Combi, another study found that only one non-commercial algorithm, the Liljestrand-Zander technique which is incorporated into the CardioQ+, had an acceptable concordance of 94% when compared to OD, to vasopressor changes 6 . Unlike this study, they did not compare proprietary arterial pressure monitors, FloTrac and LiDCOrapid, but did find poor concordance to the Windkessel (47%) and Pressure Root Mean Square (43%) method utilised in part by these devices.
Fluid-responsive parameters
While change in the CO to a fluid bolus represents the traditional mechanism of optimising a Frank-Starling association, preload-responsive parameters also have the ability to guide fluid therapy. The OD in our study had three parameters, SVI, FlowTime OD and SVV OD which had some ability to predict fluid responsiveness. We found an optimal FlowTime OD threshold of 360 ms consistent with previous reports 25 but the strength of the ROC analysis is only moderate and is not replicated by Guinot et al 26 . SVI OD in our study had some ability to predict fluid resposiveness which supports its incorporation in GDT algorithms 27 . However, a single optimum threshold cannot be determined with certainty from this study. While an SVI OD of 51.3 ml has good sensitivity (91%), its specificity is low (55%). Given the risk of GDT may be an inadvertent fluid load 28 we would recommend a lower threshold such as SVI OD 39.7ml which has a lower sensitivity (65%) but better specificity (75%). This would be in keeping with Cannesson's grey zone approach to preload-sensitive parameters which recommends establishing the thresholds for optimal sensitivity and specificity rather than a single threshold, allowing the clinician to choose the best threshold according to clinical need 12 .
The FT parameter of SVV FT , optimal threshold 11% (AUC 0.759), also had some ability to predict fluid responsiveness (this is similar to other studies, e.g. Hoiseth et al AUC 0.73 29 ); while SVI FT did not.
LI parameters of PPV LI , SVV LI and SVI LI had limited ability to predict fluid responsiveness, but the confidence limits were wide. There are a number of reasons why this study suggested lower predictive ability compared to previous studies, such as the rapidly changing haemodynamics of an intraoperative setting, a lower tidal volume, and a more modest fluid bolus. However, we believe our study assessed these monitors under 'real world' intraoperative conditions. Overall no single parameter amongst the three devices offered reliable ability to predict fluid responsiveness under these study conditions.
Limitations
The FloTrac has been subject to newer versions that have led to a reduction in the percentage error from earlier versions compared to version 3 30 . Our study utilised FT version 1.14 and 3.0, so the bias and percentage error compared to current versions of FloTrac may be higher. In relation to concordance, there is a paucity of studies across the different versions with no evidence of improved concordance with newer versions 5, 22 . The LiDCOrapid technology is based on the Pressure Root Mean Square method (pulseCO TM ) and has not significantly changed its algorithm. As arterial pressure-derived cardiac outputs are reliant on an accurate waveform, care was taken to avoid a damped waveform during the measurement protocol. In clinical use, the loss of cardiac output measurements would be coupled with the loss of an accurate arterial pressure waveform.
Rapidly changing intraoperative haemodynamics are challenging environments for cardiac output measurements because true steady state may be impossible to achieve. However, it is in this environment that these devices are being utilised for GDT 31, 32 .
Polar plot analyses have been increasingly used to quantify the mean angle of bias and radial limits of agreement 10 but it has been argued that they represent an increase in complexity without definite advantages in trend analysis 33 . As a result, we have sought to highlight the key differences in agreement using concordance plots only.
Finally, this is a study of agreement rather than accuracy as we did not utilise a gold standard as a reference such as thermodilution which would require a pulmonary artery catheter. As a surrogate gold standard, thermodilution has its own limitations in accuracy and may be no more accurate than other cardiac output monitors 3, 34 . A pulmonary artery catheter would represent an additional unjustifiable risk in patients undergoing elective non-cardiac surgery. Conducting sets of three or more intermittent bolus thermodilution measurements before and after each event would severely limit the number of events that could be captured due to the increased time that would be required. For the assessment of fluid-responsive parameters, fluid responsiveness was defined as the change in cardiac output detected by each monitor specific to that parameter. While this 'within monitor' assessment does not allow for conclusions of accuracy, it does allow for observations of agreement between monitors.
Conclusion
Our assessment of bias and limits of agreement found reasonable agreement between the two arterial pressure CO monitors, FT and LI, but there was a tendency to overestimate compared to the OD at lower cardiac outputs and underestimate cardiac output compared to OD at higher cardiac outputs.
We found reasonable concordance between the two arterial pressure CO devices in detecting changes in cardiac output in response to all interventions. However, the concordance between the arterial pressure CO devices and the OD was poorer and especially poor (30%) for cardiac output responses to metaraminol. Of the fluid-responsive parameters we studied, only SVI OD , FlowTime OD , SVV OD and SVV FT had some ability to predict fluid-responsiveness, but would not be deemed reliable using ROC analysis.
These differences in performance of Doppler and arterial pressure-derived CO monitors indicate that these technologies should not be assumed to be interchangeable for the measurement of CO and its response to clinical interventions. As there are differences in measurements of the same physiological response, it can be inferred that not all three devices can be accurate.
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